EICHORCondition: Systemic Lupus Erythematosus · Sponsor: Novartis Pharmaceuticals
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
The purpose of this study is to evaluate long-term safety and tolerability of ianalumab in participants with systemic lupus erythematosus who have previously completed the treatment period in one of the two SIRIUS-SLE core studies (CVAY736F12301 or CVAY736F12302).
This description comes directly from the study's public registry record.
Novartis Pharmaceuticals · 1-888-669-6682 · novartis.email@novartis.com
Novartis Pharmaceuticals · +41613241111 · novartis.email@novartis.com
Always discuss trial participation with your own doctor first.
| Pinnacle Research Group Llc | Anniston, Alabama, United States | Recruiting |
| Providence Medical Center | Burbank, California, United States | Recruiting |
| Advanced Medical Research | La Palma, California, United States | Recruiting |
| Millennium Clinical Trials | Westlake Village, California, United States | Active Not Recruiting |
| University of Colorado Denver | Aurora, Colorado, United States | Recruiting |
| Clinical Res Of W Florida | Clearwater, Florida, United States | Recruiting |
| GNP Research | Cooper City, Florida, United States | Recruiting |
| IRIS Research and Development | Plantation, Florida, United States | Recruiting |
| Clinical Research of West Florida Inc | Tampa, Florida, United States | Recruiting |
| Parris and Associates Rheumatology | Lawrenceville, Georgia, United States | Recruiting |
| Robert A Hozman MD SC | Skokie, Illinois, United States | Recruiting |
| Willow Rheumatology Wellness | Willowbrook, Illinois, United States | Recruiting |
+ 131 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06133972